INTRODUCTION
============

'Parent-of-origin effects' is a broad term that encompasses two distinct phenomena---parent-of-origin effects on transcription, and parent-of-origin effects on mutation rates. A parent-of-origin effect on transcription, or genomic imprinting, results from epigenetic modification of the genome which, in turn, results in unequal transcription of parental alleles. For these imprinted genes, expression of the alleles is dependent upon the sex of the parent from which they were inherited ([@b1]). A parent-of-origin effect on mutation rate, however, refers to the preferential occurrence of some spontaneous mutations in either the father\'s or the mother\'s germ line. The mechanisms by which these spontaneous mutations arise depend upon the parental germ line in which the mutation occurred. For example, base substitutions, arising from errors during replication, tend to be paternal in origin, owing to the greater number of cell divisions in spermatogenesis as compared with oogenesis ([@b2]). Chromosomal abnormalities, however, tend to be maternal in origin. Oocytes are arrested in prophase of meiosis I until sexual maturity, when one oocyte per month is selected to resume the cell cycle. It is thought that the longer the oocytes are arrested in meiosis, the greater the chance for a nondisjunction event to occur ([@b3]). Advanced parental age seems to influence the development of some, but not all, of these mutations (also referred to as the paternal or maternal age effect) ([@b2]).

THE DATABASE
============

In 1998, the catalogue of imprinted genes and parent-of-origin effects was first published ([@b4]). This catalogue served as the basis for the development of a more comprehensive, searchable, online database, made publicly available in 1999. The original database included 41 imprinted genes, and other parent-of-origin effects, including some records on the parental origin of spontaneous mutations ([@b5]).

We have added recently a comprehensive section on spontaneous mutations that show a bias with respect to their parental origin. This new part of the database can be searched according to mutation type, disorder, chromosomal location, gene name and inheritance pattern. Each entry in the database is hyperlinked to the relevant reference in PubMed. Outcomes of the search are presented in a tabular format with the following information: disorder, inheritance pattern, incidence of disorder, gene name, chromosomal location, evidence of a paternal or maternal age effect, mutation type and any recurrent mutations associated with a parent-of-origin effect, number of paternal mutations, number of maternal mutations and PubMed reference (e.g. [Table 1](#tbl1){ref-type="table"}). In the case of base substitutions, data are separated according to the type of base substitution (missense mutation, nonsense mutation or splice site mutation), whether the mutation is a transition or transversion mutation, and whether the base substitution falls within a CpG dinucleotide. For deletions and insertions, the distinction is made between large deletions and insertions (\>20 bp) and small deletions and insertions (\<20 bp). This size distinction is made based upon the possibility of different mechanisms contributing to these different types of mutations, and therefore potentially different parental origins ([@b2]). In general, large deletions do not appear to have a parent-of-origin effect, whereas small deletions tend to be more paternal in origin.

Currently, \>1700 mutations with a parent-of-origin effect are catalogued in this database. These mutations are found in 59 different disorders. Large deletions comprise the largest category in this database, with ∼900 mutations catalogued. Base substitutions form the second largest category in the database, with ∼400 mutations.

The other major section of the database includes known imprinted genes and observations of other putatively imprinted genes. Of the 464 database entries, 152 entries describe 85 unique imprinted genes in humans, mice, cattle, sheep, pigs, rats and marsupials, as well as 14 genes for which the evidence of imprinting is conflicting or provisional. The imprinted genes have been described recently in a review publication ([@b17]). The phenotypic consequences of human and mouse uniparental disomies are described in 31 entries. An additional 186 entries report parent-of-origin effects in the transmission or linkage of simple and complex genetic conditions including human diseases and animal quantitative traits.

DATABASE ACCESS AND USAGE
=========================

The imprinted gene and parent-of-origin effect database is housed at the University of Otago in Dunedin, New Zealand and can be accessed at [www.otago.ac.nz/IGC](www.otago.ac.nz/IGC). The database is maintained by the corresponding authors who welcome submissions and comments and is updated as new literature is published. Submissions to the imprinted gene database should be directed to I.M.M. and submissions to the parental origin of *de novo* mutations database should be directed to R.L.G. Users of the database are asked to cite this article in their publication.
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Figures and Tables
==================

###### 

Example of report for parental origin of *de novo* mutations showing base substitutions within a CpG dinucleotide

  Disorder                                Inheritance   Incidence                    Gene    Chromosomes    Paternal age effect   Maternal age effect   Recurrent mutations   Mutation type   TS/TV    No. of pat. cases   No. of mat. cases   Reference
  --------------------------------------- ------------- ---------------------------- ------- -------------- --------------------- --------------------- --------------------- --------------- -------- ------------------- ------------------- ------------------------------------------
  Apert                                   AD            1/160 000                    FGFR2   10q26          Y                     N                     S252W (C→G)           P(MS)--CpG      TV       57                  0                   Moloney,D.M. *et al*. (1996) ([@b6])
                                                                                                                                                        P253R (C→G)                                                                            
  Achondroplasia                          AD            1/10 000                     FGFR3   4p16.3         Y                     N                     G380R (G→A)           P(MS)--CpG      TS, TV   40                  0                   Wilkin DJ (1998) ([@b7])
                                                                                                                                                        G380R (G→C)                                                                            
  Hutchinson--Gilford Progeria syndrome   AD                                         LMNA    1q21.2         Y                     N                     G608G (C→T)           P(MS)--CpG      TS       4                   0                   Eriksson M *et al*. (2003) ([@b8])
  Hutchinson--Gilford Progeria syndrome   AD                                         LMNA    1q21.2         Y                     N                     G608G (C→T)           P(MS)--CpG      TS       3                   0                   D\'Apice MR *et al*. (2004) ([@b9])
  Muenke syndrome                         AD            1/30 000                     FGFR3   4p16.3         Y                                           c749C→G               P(MS)--CpG      TV       10                  0                   Rannan-Eliya SV *et al*. (2004) ([@b10])
  von Hippel-Lindau                       AD            1/36 000                     VHL     3p25--p26      N                                                                 P(MS)--CpG      TS       2                   0                   Richards FM *et al*. (1995) ([@b11])
  Rett syndrome                           XD            1/10 000--1/15 000 females   MECP2   Xq28                                                       R294X                 P(MS)--CpG      TV       0                   1                   Girard M *et al*. (2001) ([@b12])
  Rett syndrome                           XD            1/10,000-1/15,000 females    MECP2   Xq28                                                       R294X                 P(NS)--CpG      TS       4                   0                   Girard M *et al*. (2001) ([@b12])
  Rett syndrome                           XD            1/10 000--1/15 000 females   MECP2   Xq28                                                       R168X (C→T)           P(NS)--CpG      TS       2                   1                   Amir RE *et al*. (2000) ([@b13])
                                                                                                                                                        R270X (C→T)                                                                            
  Rett syndrome                           XD            1/10 000--1/15 000 females   MECP2   Xq28           N                                                                 P(MS)--CpG      TS       7                   1                   Trappe R *et al*. (2001) ([@b14])
  Rett syndrome                           XD            1/10 000--1/15 000 females   MECP2   Xq28           N                                           c502C→T c880C→T       P(NS)--CpG      TS       13                  0                   Trappe R *et al*. (2001) ([@b14])
                                                                                                                                                        R270X(C→T)                                                                             
  Hemophilia B                            XR            1/30 000                     FIX     Xq27.1--27.2   Y                     Y                                           P--CpG          TS       6                   3                   Ketterling RP *et al*. (1999) ([@b15])
  Hemophilia B                            XR            1/30 000                     FIX     Xq27.1--27.2                                                                     P--CpG          TS       8                   12                  Green PM *et al*. (1999) ([@b16])

AD, autosomal dominant; XD, X-linked dominant; XR, X-linked recessive; P, point mutation; MS, missense mutation; NS, nonsense mutation; CpG, mutation in a CpG dinucleotide; TS, transition mutation; TV, transversion mutation.

[^1]: Correspondence may also be addressed to Ian M. Morison. Tel: +64 3 479 5391; Fax +64 3 479 7738; Email: <ian.morison@otago.ac.nz>
